Carole Beck
- Postdoc; PhD
- +47 2278 14 24
Publications 2024
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers
Int J Mol Sci, 25 (1)
DOI 10.3390/ijms25010586, PubMed 38203757
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586
Int J Mol Sci, 25 (18)
DOI 10.3390/ijms251810024, PubMed 39337718
Publications 2023
Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy
Biomedicines, 11 (2)
DOI 10.3390/biomedicines11020459, PubMed 36830995
Publications 2022
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
Mol Ther Oncolytics, 26, 189-206
DOI 10.1016/j.omto.2022.06.007, PubMed 35860008
Publications 2019
Mediator of DNA Damage Checkpoint Protein 1 Facilitates V(D)J Recombination in Cells Lacking DNA Repair Factor XLF
Biomolecules, 10 (1)
DOI 10.3390/biom10010060, PubMed 31905950
Publications 2018
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers
Cell Death Differ, 26 (9), 1615-1630
DOI 10.1038/s41418-018-0233-1, PubMed 30442946
Robust DNA repair in PAXX-deficient mammalian cells
FEBS Open Bio, 8 (3), 442-448
DOI 10.1002/2211-5463.12380, PubMed 29511621
Normal development of mice lacking PAXX, the paralogue of XRCC4 and XLF
FEBS Open Bio, 8 (3), 426-434
DOI 10.1002/2211-5463.12381, PubMed 29511619
Publications 2014
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
Nucleic Acids Res, 42 (9), 5616-32
DOI 10.1093/nar/gku174, PubMed 24598253
Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3
Exp Cell Res, 329 (1), 18-25
DOI 10.1016/j.yexcr.2014.07.003, PubMed 25017100